|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-6-11
|
|
pubmed:abstractText |
The majority of high-dose chemotherapy (HDC)-related complications results from bone marrow aplasia, but the graft infusion per se may cause adverse reactions due to the injection of both dimethyl sulfoxide (DMSO) and cell lysis products. We evaluated the feasibility of a two-step chemotherapy regimen with peripheral blood progenitor cell (PBPC) support in association with a novel procedure to remove DMSO and products of cell lysis from the cryopreserved cells.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
pubmed-author:BergaglioMM,
pubmed-author:BertelliGG,
pubmed-author:BertoglioSS,
pubmed-author:BighinCC,
pubmed-author:Del MastroLL,
pubmed-author:LambiaseAA,
pubmed-author:MelioliGG,
pubmed-author:PietraGG,
pubmed-author:RossiLL,
pubmed-author:SeminiEE,
pubmed-author:SertoliM RMR,
pubmed-author:SignoriniAA,
pubmed-author:VenturiniMM,
pubmed-author:ViscoliCC
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
12
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
505-8
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11398884-Adult,
pubmed-meshheading:11398884-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:11398884-Breast Neoplasms,
pubmed-meshheading:11398884-Carboplatin,
pubmed-meshheading:11398884-Centrifugation,
pubmed-meshheading:11398884-Combined Modality Therapy,
pubmed-meshheading:11398884-Cryoprotective Agents,
pubmed-meshheading:11398884-Cyclophosphamide,
pubmed-meshheading:11398884-Dimethyl Sulfoxide,
pubmed-meshheading:11398884-Epirubicin,
pubmed-meshheading:11398884-Female,
pubmed-meshheading:11398884-Fluorouracil,
pubmed-meshheading:11398884-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:11398884-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:11398884-Humans,
pubmed-meshheading:11398884-Middle Aged,
pubmed-meshheading:11398884-Neoplasm Staging,
pubmed-meshheading:11398884-Recombinant Proteins,
pubmed-meshheading:11398884-Remission Induction,
pubmed-meshheading:11398884-Treatment Outcome
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Intensified chemotherapy supported by DMSO-free peripheral blood progenitor cells in breast cancer patients.
|
|
pubmed:affiliation |
Department of Medical Oncology, National Cancer Research Institute, Genoa, Italy. ldelmast@hp380.ist.unige.it
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
